This 2014 review by Matt Kaeberlein evaluates critical variables in rapamycin use for aging interventions, including optimal dosing, treatment duration, and initiation timing. While rapamycin consistently extends lifespan in animal models, most studies employ a standard dose and continuous administration, potentially missing more effective strategies. Emerging evidence suggests intermittent or
